OrbiMed raised $3B across two new life sciences funds, including more than $1B for Asia. endpoints.news/orbimed-rais...
endpoints.newsOrbiMed raises $3B in new life sciences funds, including $1B+ for AsiaOrbiMed raises $3B across two funds: $1.9B for US/Europe and $1B for Asia. Managing partner Carl Gordon cited AI and China's biopharma growth as key drivers.
0 reposts0 likes